NCT Number: NCT00544622
Structured Stroke Management Improves Outcome at 6 Months
Background/Aim of the study: To further reduce the 6 months stroke morbidity and mortality in a high volume stroke hospital and to compare the results with national and international data.
Methods: 204 consecutive stroke patients are analyzed in a prospective study in a single center teaching institution. The intervention consists of a structured therapeutic chain of 290 collaborating GPs, a standardised acute hospital proceeding overlapping with an early integrated neurovascular rehabilitation within the same institution. Primary endpoints include death and dependence at 6 months, secondary endpoints are the length of hospital stay (LOS) and the quantitative analysis of physical and psychosocial impairments. The data are directly compared with the same endpoints of the Swiss subgroup of the international stroke trial (IST).
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- An acute cerebrovascular event (ischemic stroke or intra-cerebral bleeding (ICB)) with the signs and symptoms of an acute stroke according to the World Health Organisation definition of acute stroke14 within the last 12 hours without the need or possibility of a neurosurgical intervention
- No thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
- The informed consent of the patient or, if not possible, of the relatives
- Living at home before the event
- Lack of participation in another trial.
Exclusion criteria
- Thrombolytic therapy within the first 3 hours (in order to allow the correct comparison with the Swiss cohort of the IST trial
- No informed consent of the patient or, if not possible, of the relatives
- Not living at home before the event
- Participation in another trial (26 patients were excluded because of TIA with full recovery within 24 hours after the event)
Treatment and study plan
Primary outcomes
-
Mortality, dependence, psychoscial outcome
-
Mortality, dependence and psychosocial outcome
Time frame: 6 months endpoint
Sponsors and collaborators
Lead sponsor
Kantonsspital Baden
Other
Collaborators
- 407 Doctors
Registry information
Important dates
- Study start
- 2002
- Study completion
- 2003
- First posted
- Oct 16, 2007
- Registry last updated
- Oct 17, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Women's Health Initiative Strong and Healthy Study
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsTemporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsComparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients
NCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsImpact of COVID-19 Vaccines on Cerebrovascular Health
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details